Health Sciences In The Media

The number of weekly COVID-19 deaths in Arizona recently hit a high-water mark. It’s one of the latest and most concrete signs that the pandemic is getting better statewide, although the virus still presents a significant risk. “For the first time I’m confident that we’ve had a peak in deaths,” said Joe Gerald, an associate professor with the University of Arizona’s Mel and Enid Zuckerman College of Public Health. “Things are getting markedly better. That's awesome.”

Dr. Murtaza Akhter, an assistant professor at the University of Arizona College of Medicine – Phoenix and an emergency room physician, answers questions from viewers about coronavirus.

The pandemic has also made it more difficult and scarier for some individuals to receive treatment for their substance use disorder from both treatment clinics or emergency departments, says Todd Vanderah, head of the Department of Pharmacology in the University of Arizona College of Medicine – Tucson.

Rather than see productivity plummet with undergraduates out of the lab, Michael Johnson, a microbiologist at the University of Arizona College of Medicine - Tucson, and other researchers have pivoted to focus on renewing their existing grants, analyzing neglected data, and writing up results for publication. "There's still a lot of work that can be done remotely that is valuable and contributory to the field," Johnson said.

Amanda Wilson, an environmental health sciences doctoral candidate in the University of Arizona Mel and Enid Zuckerman College of Public Health, is lead author of a recent study published in the Journal of Hospital Infection that assessed the ability of a variety of nontraditional mask materials to protect a person from infection after 30 seconds and after 20 minutes of exposure in a highly contaminated environment.

CNN chief medical correspondent Dr. Sanjay Gupta interviews Dr. Richard Carmona, the 17th U.S. Surgeon General and head of the University of Arizona's Reentry Task Force, about the process of reopening a college campus amid the COVID-19 pandemic.

Despite the Food and Drug Administration's emergency approval of drugs such as remdesivir, there are still no strong, highly effective treatments available, especially for the sickest patients. Through a partnership with Banner Health, the University of Arizona is already running three clinical trials, with another 11 in the pipeline.

University of Arizona scientist Chris Hulme has earned $3.8 million in federal funding to further research on medications to help prevent or reverse the progression of Alzheimer's disease

Students at the University of Arizona College of Medicine – Tucson share their experiences as they study medicine amid the COVID-19 pandemic.

To better protect those serving on the front lines of battlefields or dealing with an event like the COVID-19 health crisis or potential future pandemics, scientists at the University of Arizona College of Medicine – Phoenix are leading an effort to develop a device that could easily, quickly and accurately detect pathogens and biological threats.